GENANI
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Mar 2023)
What this means for you
This application is over — abandoned 13 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88303885
- Mark type
- Stylized text
- Filed
- 15 Feb 2019
- Published for opposition
- 10 Dec 2019
- Abandoned
- 13 Mar 2023
- Attorney of record
- Alisa C. Simmons
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations for repair of organs damaged by trauma, drugs, radiation, hypoxia, or explosive device; pharmaceuticals and pharmaceutical preparations for reversing effects of aging; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for the prevention and treatment of vascular diseases or disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in skin care; astringents; pharmaceutical skin lotions; stem cells for medical purposes; pharmaceutical products and preparations; medicated preparations
Owner
- GENANI CORPORATION, CHICAGO, IL, US
- Burt, Richard, Chicago, IL, US
- Burt, Richard, Chicago, IL, US
Prosecution history
- 13 Mar 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Mar 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 24 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 May 2022 — SOU EXTENSION 5 GRANTED
- 18 May 2022 — SOU EXTENSION 5 FILED
- 21 May 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 May 2022 — SOU TEAS EXTENSION RECEIVED
- 08 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2022 — SOU EXTENSION 4 GRANTED
- 04 Feb 2022 — SOU EXTENSION 4 FILED
- 04 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 01 Dec 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 28 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jul 2021 — SOU EXTENSION 3 GRANTED
- 26 Jul 2021 — SOU EXTENSION 3 FILED